Prevalence and correlates of psychotropic medication use among older adults in Israel: Cross-sectional and longitudinal findings from two cohorts a decade apart

Aging and Mental Health

Volumn 16, Issue 5, 2012, Pages 636-647

  Blumstein, Tzvia ^a   Benyamini, Yael ^b   Chetrit, Angela ^a   Mizrahi, Eliyahu H ^c   Lerner Geva, Liat ^a,b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Community dwelling; Epidemiology (mental health); Psychotropic medications; Usage patterns

Indexed keywords

PSYCHOTROPIC AGENT;

AGED; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; INFORMATION PROCESSING; ISRAEL; LONGITUDINAL STUDY; MALE; MENTAL HEALTH; PREVALENCE; STATISTICS;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DEPRESSION; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; ISRAEL; LONGITUDINAL STUDIES; MALE; MENTAL HEALTH; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PSYCHOTROPIC DRUGS;

EID: 84862842862     PISSN: 13607863     EISSN: 13646915     Source Type: Journal    
DOI: 10.1080/13607863.2011.644262     Document Type: Article

References (42)

1. Aparasu, R.R., Mort, J.R., & Brandt, H. (2003). Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society, 51, 671-677.
2. Beland, S.G., Preville, M., Dubois, M.F., Lorrain, D., Grenier, S., Voyer, P.,. .. Moride, Y. (2010). Benzodiazepine use and quality of sleep in the community-dwelling elderly population. Aging and Mental Health, 14, 843-850.
3. Blazer, D., Hybels, C., Simonsick, E., & Hanlon, J.T. (2000). Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: A racial comparison. Journal of the American Geriatrics Society, 48, 1073-1079.
4. Blumstein, T., Shmotkin, D., Eyal, N., Shorek, A., & Lerner- Geva, L. (2008). A longitudinal evaluation of medication use among the old-Old population in Israel 1. Research on Aging, 30, 55-73.
5. Bowen, J.D., & Larson, E.B. (1993). Drug-induced cognitive impairment. Defining the problem and finding solutions. Drugs Aging, 3, 349-357.
6. Callahan, C.M. (2001). Quality improvement research on late life depression in primary care. Medical Care, 39, 772-784.
7. Colman, I., Wadsworth, M.E., Croudace, T.J., & Jones, P.B. (2006). Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort. The British Journal Psychiatry, 189, 156-160.
8. Cumming, R.G., & Klineberg, R.J. (1993). Psychotropics, thiazide diuretics and hip fractures in the elderly. The Medical Journal of Australia, 158, 414-417.
9. Dealberto, M.J., Seeman, T., McAvay, G.J., & Berkman, L. (1997). Factors related to current and subsequent psychotropic drug use in an elderly cohort. Journal of Clinical Epidemiology, 50, 357-364.
10. Fick, D., Kolanowski, A., & Waller, J. (2007). High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Aging and Mental Health, 11, 588-595.
11. Fuchs, Z., Novikov, I., Blumstein, T., Chetrit, A., Gindin, J., & Modan, B. (2003). Patterns of drug use among the community-dwelling old-old population in Israel. The Israel Medical Association Journal, 5, 346-351.
12. Geulayov, G., Lipsitz, J., & Gross, R. (2009). The epidemiology of mental health problems in primary healthcare in Israel. In I. Levav (Ed.), Psychiatric and behavioral disorders in Israel: From epidemiology to mental health action (Chap 17, pp. 286-310). Jerusalem: Gefen Publishing House.
13. Gleason, P.P., Schulz, R., Smith, N.L., Newsom, J.T., Kroboth, P.D., Kroboth, F.J.,. .. Psaty, B.M. (1998). Correlates and prevalence of benzodiazepine use in community-dwelling elderly. Journal of General Internal Medicine, 13, 243-250.
14. Grinshpoon, A., Marom, E., Weizman, A., & Ponizovsky, A.M. (2007). Psychotropic drug use in israel: Results from the National Health Survey. Primary Care Companion to The Journal of Clinical Psychiatry, 9, 356-363.
15. Hanlon, J.T., Horner, R.D., Schmader, K.E., Fillenbaum, G.G., Lewis, I.K., Wall Jr, W.E.,. .. Cohen, H.J. (1998). Benzodiazepine use and cognitive function among community- dwelling elderly. Clinical Pharmacology and Therapeutics, 64, 684-692.
16. Helgason, T., Tomasson, H., & Zoega, T. (2004). Antidepressants and public health in Iceland. Time series analysis of national data. The British Journal of Psychiatry, 184, 157-162.
17. Herings, R.M., Stricker, B.H., de Boer, A., Bakker, A., & Sturmans, F. (1995). Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Archives of Internal Medicine, 155, 1801-1807.
18. Isacson, D., & Smedby, B. (1988). Patterns of psychotropic drug use in a Swedish community. Scandinavian Journal of Primary Health Care, 6, 51-58.
19. Jorm, A.F., Grayson, D., Creasey, H., Waite, L., & Broe, G.A. (2000). Long-term benzodiazepine use by elderly people living in the community. The Australian New Zealand Journal of Public Health, 24, 7-10.
20. Katz, S., Downs, T.D., Cash, H.R., & Grotz, R.C. (1970). Progress in development of the index of ADL. Gerontologist, 10, 20-30.
21. Katzman, R., Brown, T., Fuld, P., Peck, A., Schechter, R., & Schimmel, H. (1983). Validation of a short orientationmemory- concentration test of cognitive impairment. The American Journal of Psychiatry, 140, 734-739.
22. Lichtenstein, M.J., Griffin, M.R., Cornell, J.E., Malcolm, E., & Ray, W.A. (1994). Risk factors for hip fractures occurring in the hospital. American Journal of Epidemiology, 140, 830-838.
23. Medic (2010). Monthly ethical drug indexed compilation (Medic). Herzeliya: Shirol.
24. Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001). Secular trends in antidepressant prescribing in the UK, 1975-1998. Journal Public Health Medicine, 23, 262-267.
25. Morgan, K., Dallosso, H., Ebrahim, S., Arie, T., & Fentem, P.H. (1988). Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. British Medical Journal (Clinical Research Edition), 296, 601-602.
26. Munitz, H. (2009). Psycopharmacoepidemiology in practice. In I. Levav (Ed.), Psychiatric and behavioral disorders in Israel: From epidemiology to mental health action (Chap 18, pp. 311-317). Jerusalem: Gefen Publishing House.
27. Olfson, M., Marcus, S.C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H.A. (2002). National trends in the outpatient treatment of depression. The Journal of the American Medical Association, 287, 203-209.
28. Paulose-Ram, R., Safran, M.A., Jonas, B.S., Gu, Q., & Orwig, D. (2007). Trends in psychotropic medication use among US adults. Pharmacoepidemiology and Drug Safety, 16, 560-570.
29. Preville, M., Hebert, R., Boyer, R., & Bravo, G. (2001). Correlates of psychotropic drug use in the elderly compared to adults aged 18-64: Results from the Quebec Health Survey. Aging and Mental Health, 5, 216-224.
30. Proctor, E.K., Hasche, L., Morrow-Howell, N., Shumway, M., & Snell, G. (2008). Perceptions about competing psychosocial problems and treatment priorities among older adults with depression. Psychiatric Services, 59, 670-675.
31. Radloff, L.S. (1977). The CES-D Scale: A self report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
32. Shmotkin, D., Blumstein, T., & Modan, B. (2003). Beyond keeping active: Concomitants of being a volunteer in old-old age. Psychology and Aging, 18, 602-607.
33. Shmotkin, D., Lerner-Geva, L., Cohen-Mansfield, J., Blumstein, T., Eyal, N., Shorek, A.,. .. Hazan, H. (2010). Profiles of functioning as predictors of mortality in old age: The advantage of a configurative approach. Archives of Gerontology and Geriatrics, 51, 68-75.
34. Sonnenberg, C.M., Beekman, A.T., Deeg, D.J., & van Tilburg, W. (2003). Drug treatment in depressed elderly in the Dutch community. International Journal Geriatric Psychiatry, 18, 99-104.
35. Stewart, R.B., Marks, R.G., Padgett, P.D., & Hale, W.E. (1994). Benzodiazepine use in an ambulatory elderly population: A 14-year overview. Clinical Therapeutics, 16, 118-124.
36. Taylor, S., McCracken, C.F., Wilson, K.C., & Copeland, J.R. (1998). Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. The British Journal of Psychiatry, 173, 433-438.
37. Unutzer, J., & Bruce, M.L. (2002). The elderly. Mental Health Services Research, 4, 245-247.
38. van Hulten, R., Leufkens, H.G., & Bakker, A. (1998). Usage patterns of benzodiazepines in a Dutch community: A 10-year follow-up. Pharmacy World and Science, 20, 78-82.
39. Walter-Ginzburg, A., Blumstein, T., Chetrit, A., & Modan, B. (2002). Social factors and mortality in the old-old in Israel: The CALAS study. The Journal of Gerontology Series B Psychological Sciences and Socical Sciences, 57, S308-S318.
40. WHO Collaborative Center for Drug statistics (2010). Guidelines for ATC classification and DDD assignment. Oslo, Norway: WHO.
41. Wittkampf, L.C., Smeets, H.M., Knol, M.J., Geerlings, M.I., Braam, A.W., & De Wit, N.J. (2010). Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands. Social Psychiatry and Psychiatric Epidemiology, 45, 819-826.
42. Zuvekas, S.H. (2005). Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. Health Affairs (Millwood), 24, 195-205.